Successful treatment of an EBV‐positive HIV‐associated polymorphic B‐cell lymphoproliferative disorder by rituximab monotherapy

Successful treatment of an EBV‐positive HIV‐associated polymorphic B‐cell lymphoproliferative disorder by rituximab monotherapy

Bibliographic Details
Main Authors:	Mohamad Sabbah, Sylvain Choquet, Agathe Maillon, Clotilde Bravetti, Marine Baron, Frédéric Charlotte, Damien Roos‐Weil
Format:	Article
Language:	English
Published:	Wiley 2021-08-01
Series:	eJHaem
Subjects:	HIV polymorphic B‐cell lymphoproliferative disorder rituximab
Online Access:	https://doi.org/10.1002/jha2.247

Similar Items

X‐linked lymphoproliferative syndrome associated with Epstein–Barr virus encephalitis and lymphoproliferative disorder
by: Takeo Mukai, et al.
Published: (2023-09-01)

Case report: EBV-related eye orbits and sinuses lymphohistiocytic infiltration responsive to rituximab in a patient with X lymphoproliferative syndrome type 1
by: Giuliana Giardino, et al.
Published: (2024-04-01)

Central Nervous System Involvement of Epstein Barr Virus Associated Lymphoproliferative Disorder in a Child with Acute Lymphoblastic Leukemia: Successful Treatment with Rituximab and Interferon-Alpha
by: Berna Atabay, et al.
Published: (2013-03-01)

Recent Advances in Adult Post-Transplant Lymphoproliferative Disorder
by: Mariam Markouli, et al.
Published: (2022-12-01)

The diagnosis of lymphoproliferative diseases /
by: Gatter, Kevin 534567
Published: (c201)

HHV-8 and EBV Positive Lymphoproliferative Disease: A Challenging Case
by: Göksenil BÜLBÜL, et al.
Published: (2022-05-01)

Epstein-Barr Virus-Negative Post-Transplant Lymphoproliferative Diseases: Three Distinct Cases from a Single Center
by: Şule Mine Bakanay, et al.
Published: (2014-02-01)

Newly onset cytopenias not always indicate a relapsing AML after allogeneic HSCT, a case of non-destructive post transplant lymphoproliferative disorder
by: Süreyya Yiğit Kaya, et al.
Published: (2023-01-01)

Natural Killer Cells in Post-Transplant Lymphoproliferative Disorders
by: Cecilia Nakid-Cordero, et al.
Published: (2021-04-01)

Rituximab and Cytokine Release Syndrome
by: Hrishikesh S. Kulkarni, et al.
Published: (2012-03-01)

New Evidence of Significant Association between EBV Presence and Lymphoproliferative Disorders Susceptibility in Patients with Rheumatoid Arthritis: A Systematic Review with Meta-Analysis
by: Ana Banko, et al.
Published: (2022-01-01)

Development of anti-rituximab antibodies in rituximab-treated patients: Related parameters & consequences
by: Fatemeh Saffari, et al.
Published: (2022-01-01)

Autoimmune Lymphoproliferative Syndrome (ALPS): A Case Report
by: Yazan S. Mousa
Published: (2016-12-01)

Rituximab resistance in ITP and beyond
by: Zhengrui Xiao, et al.
Published: (2023-07-01)

Rituximab Monotherapy versus Rituximab and Bortezomib Combination Therapy for Treatment of Non-paraneoplastic Autoimmune Retinopathy
by: Arash Maleki, et al.
Published: (2022-11-01)

The BCL‐2 family protein inhibitor ABT‐737 as an additional tool for the treatment of EBV‐associated post‐transplant lymphoproliferative disorders
by: Aude Robert, et al.
Published: (2020-10-01)

Differential Expression of Proteins in an Atypical Presentation of Autoimmune Lymphoproliferative Syndrome
by: Dulce María Delgadillo, et al.
Published: (2022-05-01)

Autoimmune Lymphoproliferative Syndrome (ALPS) in a Boy with Massive Lymphadenopathy
by: Hamid Reza Kianifar, et al.
Published: (2010-09-01)

Liquid Biopsy in Cancer: Focus on Lymphoproliferative Disorders
by: Francesco D. Savino, et al.
Published: (2022-10-01)

A clinicopathologic study of orbital and ocular adnexal lymphoproliferative lesions with immunohistochemical staining of indeterminate cases
by: "Ghasemi M, et al.
Published: (2003-05-01)

Lymphoproliferative Syndrome in Pediatrist and Infectiologist Practice
by: E. N. Simovanyan, et al.
Published: (2010-06-01)

Post-transplant lymphoproliferative disease
by: Nieto-Ríos, John Fredy, et al.
Published: (2016-07-01)

Issue of predicting the risk of thromboembolic complications in patients with lymphoproliferative diseases
by: S. V. Ignatiev, et al.
Published: (2022-04-01)

Targeted Delivery of BZLF1 to DEC205 Drives EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative Disease
by: Elshafa Hassan Ahmed, et al.
Published: (2021-05-01)

Host microRNAs are decreased in pediatric solid-organ transplant recipients during EBV+ Post-transplant Lymphoproliferative Disorder
by: Ayantika Sen, et al.
Published: (2022-10-01)

Lymphoproliferative diseases in primary Sjogren's syndrome
by: V. i. Vasiljev, et al.
Published: (2022-11-01)

Longitudinal analysis of the impact of rituximab on circulating EBV miRNAs in three paediatric kidney transplant recipients
by: Jaythoon Hassan, et al.
Published: (2024-02-01)

Classic Hodgkin Lymphoproliferative Diseases Clonally Unrelated to B-Chronic Lymphocytic Leukemia Successfully Treated with Bendamustine Plus Rituximab
by: Shinya Rai, et al.
Published: (2018-09-01)

Hepatic and lung methotrexate-associated polymorphic lymphoproliferative disorders arising during postoperative follow-up of renal cell carcinoma: a case report
by: Yoshi Miyamoto, et al.
Published: (2023-12-01)

Dysregulation of FBW7 in malignant lymphoproliferative disorders
by: Xin Wan, et al.
Published: (2022-11-01)

Predictive risk factors for the development of diseases with lymphoproliferative syndrome in children
by: R. F. Makhmutov
Published: (2021-10-01)

Does Double Mean Trouble? Coexistence of Myeloproliferative and Lymphoproliferative Neoplasms
by: Danijela Lekovic, et al.
Published: (2024-03-01)

Addition of rituximab in relapsed/refractory chronic lymphocytic leukemia after progression on venetoclax monotherapy
by: Sasanka Handunnetti, et al.
Published: (2021-05-01)

CD137 deficiency because of two novel biallelic TNFRSF9 mutations in a patient presenting with severe EBV‐associated lymphoproliferative disease
by: Kefeng Shen, et al.
Published: (2023-01-01)

EXPERIENCE WITH RITUXIMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Mikhail Sergeyevich Protopopov, et al.
Published: (2013-02-01)

USE OF RITUXIMAB IN PATIENTS WITH LUPUS NEPHRITIS
by: Anna Vasilyevna Torgashina, et al.
Published: (2010-08-01)

Low-dose total skin electron beam therapy for refractory cutaneous CD30 positive lymphoproliferative disorders
by: Neil Panjwani, et al.
Published: (2021-01-01)

EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3)
by: Magda Zanelli, et al.
Published: (2021-11-01)

Autoimmune Lymphoproliferative Syndrome in Children with Nonmalignant Organomegaly, Chronic Immune Cytopenia, and Newly Diagnosed Lymphoma
by: Zühre Kaya, et al.
Published: (2021-06-01)

Epstein Barr Virus-Positive Lymphoproliferative Disorder Following Lymphodepletion for MAGE A4 Adoptive Cellular Therapy in a Patient with Synovial Sarcoma: A Case Report
by: Maggie Zhou, et al.
Published: (2023-09-01)